Clinical Trials Logo

Clinical Trial Summary

The aim of this project is to develop an Augmentative and Alternative Communication intervention through the use of Eye tracker system.


Clinical Trial Description

The term "complex communication needs" includes all patients who present severe disturbances in speech and language production and/or in comprehension, in relation to oral or written communication modalities. The main purpose of Augmentative and Alternative Communication (AAC) is to promote the best possible communication for people with complex communication needs, through the use of techniques, methods and tools aimed not at replacing pre-existing communication methods but at increasing skills of natural communication through the enhancement of present skills. The Eye tracker system, thanks to allows the recording and analysis of eye movements, could be used successfully to support communication in patients with severe communication disability. The goal of this study is to develop an efficacy Augmentative and Alternative Communication intervention using eye-tracking technology for patients with severe communication disability. The secondary objective was to examine the psychosocial impact of technology for AAC on parents' perspectives and quality of life. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05808478
Study type Interventional
Source IRCCS Centro Neurolesi "Bonino-Pulejo"
Contact Francesca Cuinotta, MD, PhD
Phone 09060128257
Email francesca.cucinotta@irccsme.it
Status Recruiting
Phase N/A
Start date January 22, 2022
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Completed NCT03276559 - Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience Among Surrogate Decision-Makers of ICU Patients N/A
Recruiting NCT04697212 - Improving Communication and Healthcare Outcomes for Patients With Communication Disabilities N/A